Codexis plans $100 million IPO
This article was originally published in Scrip
Executive Summary
Codexis, a US biotech company that provides optimised biocatalysts to the pharmaceutical industry, has filed a registration statement relating to its proposed public offering of its common stock and could raise up to $100 million.